Wolverine Trading’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,350
Closed -$566K 5766
2024
Q3
$562K Buy
+2,350
New +$525K ﹤0.01% 2945
2024
Q1
Sell
-6,282
Closed -$1.15M 5150
2023
Q4
$1.08M Buy
+6,282
New +$965K ﹤0.01% 2234
2022
Q2
Sell
-1,398
Closed -$298K 5530
2022
Q1
$348K Sell
1,398
-243
-15% -$58.8K ﹤0.01% 3707
2021
Q4
$430K Sell
1,641
-208
-11% -$54K ﹤0.01% 3659
2021
Q3
$491K Sell
1,849
-9,280
-83% -$2.54M ﹤0.01% 3959
2021
Q2
$2.74M Buy
11,129
+9,616
+636% +$2.02M ﹤0.01% 1671
2021
Q1
$286K Buy
+1,513
New +$303K ﹤0.01% 4527
2020
Q4
Sell
-8,501
Closed -$1.47M 5372
2020
Q3
$1.47M Sell
8,501
-6,033
-42% -$1.11M ﹤0.01% 1719
2020
Q2
$2.74M Buy
14,534
+2,768
+24% +$453K 0.01% 1177
2020
Q1
$1.81M Buy
11,766
+1,325
+13% +$211K 0.01% 1430
2019
Q4
$1.61M Buy
10,441
+5,289
+103% +$762K ﹤0.01% 2008
2019
Q3
$688K Sell
5,152
-1,864
-27% -$244K ﹤0.01% 2293
2019
Q2
$856K Buy
+7,016
New +$777K ﹤0.01% 2192
2018
Q4
Sell
-4,194
Closed -$484K 5193
2018
Q3
$484K Sell
4,194
-3,113
-43% -$341K ﹤0.01% 3149
2018
Q2
$720K Hold
7,307
﹤0.01% 2612
2018
Q1
$720K Sell
7,307
-7,905
-52% -$747K ﹤0.01% 2612
2017
Q4
$1.29M Buy
+15,212
New +$1.26M ﹤0.01% 1942
2017
Q3
Sell
-3,095
Closed -$239K 4910
2017
Q2
$239K Buy
+3,095
New +$221K ﹤0.01% 3361

Other funds holding RMD

Wolverine Trading's RMD Position: Q4 2024 in Review

Wolverine Trading sold out of ResMed (RMD) in Q4 2024, closing a stake of 2,350 shares — an estimated $566K sold.

Wolverine Trading first reported a position in RMD in Q2 2017 and held it in 18 quarters. The position peaked at $2.74M in Q2 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Wolverine Trading reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 2,350 ResMed shares in Q4 2024, an estimated $566K.
  • Wolverine Trading first reported a position in ResMed in Q2 2017 and held it in 18 quarters.
  • Wolverine Trading's ResMed position peaked at $2.74M in Q2 2021.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.